oa The science and practice of cardiopulmonary bypass: From cross circulation to ECMO and SIRS

References

1. Sixth National Adult Cardiac Surgical Database Report: Demonstrating Quality 2008: Bridgewater B, Keogh B, et al; July 2009 – ISBN 1-903968-23-2.
2. Jacobi C. Ein betrag zur technik der kunstlichen durchblutung uberlebender organe. Arch Exp Pathol (Leipzig). 1895; 31::330–348.
   [Google Scholar]
3. Brukhonenko SS, Terebinsky S. Experience avec la tete isole du chien: I. Techniques et conditions des experiences. J Physiol Pathol Genet. 1929; 27::31.
   [Google Scholar]
4. Lillehei CW. Historical development of cardiopulmonary bypass. Cardiopulm Bypass. 1993; 1::26.
   [Google Scholar]
5. Lillehei CW, Cohen M, Warden HE, Ziegler NR, Varco RL. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet. 1955; 101::446–466.
   [Google Scholar]
6. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954; 37::171.
   [Google Scholar]
7. Kirklin JW, Dushane JW, Patrick RT, Donald DE, Hetzel PS, Harshbarger HG, Wood EH. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases. Proc Staff Meet Mayo Clin. 1955; 30:10:201–206.
   [Google Scholar]
8. Gibbon JH Jr. development of the heart-lung machine. Am J Surg. 1978; 135::608–619.
   [Google Scholar]
9. Gross CG. Claude Bernard and the constancy of the Internal Environment. The Neuroscientist. 1998; 4::5.
   [Google Scholar]
10. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005; 3:2:129–140.
    [Google Scholar]
11. Taylor KM. Honored Guest's Address. A practical affair. J Thorac Cardiovasc Surg. 1999 Sep; 118:3:394–403.
    [Google Scholar]
12. Day JR, Punjabi PP, Randi AM, Haskard DO, Landis RC, Taylor KM. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation. 2004 Oct 26; 110:17:2597–2600, Oct 26.
    [Google Scholar]
13. Evans BJ, Haskard DO, Finch JR, Hambleton IR, Landis RC, Taylor KM. The inflammatory effect of cardiopulmonary bypass on leukocyte extravasation in vivo. J Thorac Cardiovasc Surg. 2008 May; 135:5:999–1006.
    [Google Scholar]
14. Dinh PH, Corraza F, Mestdagh K, Kassengera Z, Doyen V, Michel O. Validation of the cantharidin-induced skin blister as an in vivo model of inflammation. Br J Clin Pharmacol. 2011 Dec; 72:6:912–920.
    [Google Scholar]
15. Day RM, Harbord M, Forbes A, Segal AW. Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. J Immunol Methods. 2001 Nov 1; 257:1-2:213–220.
    [Google Scholar]
16. Punjabi PP, Wyse RK, Taylor KM. Role of aprotinin in the management of patients during and after cardiac surgery. Expert Opin Pharmacother. 2000 Dec; 1:7:1353–1365, Review.
    [Google Scholar]
17. Howell N, Senanayake E, Freemantle N, Pagano D. Putting the record straight on aprotinin as safe and effective: Results from a mixed treatment meta-analysis of trials of aprotinin. J Thorac Cardiovasc Surg. 2013 Jan; 145:1:234–240.
    [Google Scholar]
18. Deanda A Jr, Spiess BD. Aprotinin revisited. J Thorac Cardiovasc Surg. 2012 Nov; 144:5:998–1002.
    [Google Scholar]